EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 352 filers reported holding EMERGENT BIOSOLUTIONS INC in Q4 2020. The put-call ratio across all filers is 1.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $605,419 | -20.1% | 179,118 | +73.7% | 0.00% | -50.0% |
Q2 2023 | $757,866 | -62.8% | 103,111 | -49.1% | 0.00% | -50.0% |
Q1 2023 | $2,038,359 | -68.3% | 202,419 | -63.1% | 0.00% | -73.3% |
Q4 2022 | $6,430,277 | +22.1% | 549,127 | +118.9% | 0.02% | +15.4% |
Q3 2022 | $5,266,000 | +51.5% | 250,874 | +118.8% | 0.01% | +62.5% |
Q2 2022 | $3,475,000 | -1.5% | 114,639 | +33.4% | 0.01% | +14.3% |
Q1 2022 | $3,529,000 | -83.6% | 85,951 | -82.7% | 0.01% | -82.1% |
Q4 2021 | $21,539,000 | +18.5% | 495,500 | +36.5% | 0.04% | +14.7% |
Q3 2021 | $18,181,000 | -57.2% | 363,113 | -46.1% | 0.03% | -53.4% |
Q2 2021 | $42,473,000 | +25.5% | 674,279 | +83.8% | 0.07% | +32.7% |
Q1 2021 | $33,844,000 | +107.4% | 366,834 | +101.5% | 0.06% | +89.7% |
Q4 2020 | $16,315,000 | +197.8% | 182,088 | +243.5% | 0.03% | +222.2% |
Q3 2020 | $5,478,000 | -6.2% | 53,014 | -28.2% | 0.01% | 0.0% |
Q2 2020 | $5,839,000 | +38.6% | 73,831 | +1.4% | 0.01% | +28.6% |
Q1 2020 | $4,214,000 | -18.6% | 72,825 | -24.1% | 0.01% | +16.7% |
Q4 2019 | $5,177,000 | -23.3% | 95,953 | -25.7% | 0.01% | -25.0% |
Q3 2019 | $6,748,000 | -24.9% | 129,066 | -30.6% | 0.01% | -20.0% |
Q2 2019 | $8,990,000 | -31.5% | 186,092 | -28.4% | 0.01% | -28.6% |
Q1 2019 | $13,130,000 | -20.7% | 259,892 | -6.9% | 0.01% | -26.3% |
Q4 2018 | $16,550,000 | -6.8% | 279,176 | +3.5% | 0.02% | +11.8% |
Q3 2018 | $17,757,000 | +27.0% | 269,746 | -2.6% | 0.02% | +21.4% |
Q2 2018 | $13,982,000 | -21.8% | 276,936 | -18.4% | 0.01% | -26.3% |
Q1 2018 | $17,870,000 | +15.0% | 339,402 | +1.5% | 0.02% | +18.8% |
Q4 2017 | $15,544,000 | +44.2% | 334,484 | +25.5% | 0.02% | +23.1% |
Q3 2017 | $10,777,000 | +166.0% | 266,434 | +123.0% | 0.01% | +160.0% |
Q2 2017 | $4,052,000 | -7.5% | 119,489 | -20.8% | 0.01% | -16.7% |
Q1 2017 | $4,381,000 | -30.4% | 150,856 | -21.3% | 0.01% | -33.3% |
Q4 2016 | $6,299,000 | -2.7% | 191,801 | -6.6% | 0.01% | -10.0% |
Q3 2016 | $6,471,000 | +100.5% | 205,245 | +78.9% | 0.01% | +66.7% |
Q2 2016 | $3,227,000 | -32.3% | 114,751 | -12.5% | 0.01% | -33.3% |
Q1 2016 | $4,767,000 | -50.6% | 131,139 | -45.6% | 0.01% | -47.1% |
Q4 2015 | $9,648,000 | +42.3% | 241,154 | +1.4% | 0.02% | +21.4% |
Q3 2015 | $6,779,000 | -29.4% | 237,941 | -18.3% | 0.01% | -26.3% |
Q2 2015 | $9,600,000 | +16.8% | 291,368 | +2.0% | 0.02% | 0.0% |
Q1 2015 | $8,219,000 | +12.4% | 285,765 | +6.4% | 0.02% | +26.7% |
Q4 2014 | $7,310,000 | +24.0% | 268,463 | -3.0% | 0.02% | -6.2% |
Q3 2014 | $5,895,000 | -30.5% | 276,636 | -26.8% | 0.02% | -30.4% |
Q2 2014 | $8,484,000 | -26.3% | 377,736 | -17.0% | 0.02% | -34.3% |
Q1 2014 | $11,506,000 | +5.1% | 455,336 | -4.4% | 0.04% | +6.1% |
Q4 2013 | $10,951,000 | +19.4% | 476,336 | -1.1% | 0.03% | +3.1% |
Q3 2013 | $9,175,000 | +21.9% | 481,636 | -7.7% | 0.03% | +18.5% |
Q2 2013 | $7,527,000 | +79.3% | 522,001 | +99.4% | 0.03% | +50.0% |
Q4 2012 | $4,199,000 | – | 261,801 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Broadfin Capital, LLC | 2,080,519 | $44,336,000 | 4.65% |
GREAT POINT PARTNERS LLC | 290,000 | $6,180,000 | 2.65% |
FIDUCIARY MANAGEMENT ASSOCIATES LLC | 651,884 | $13,892,000 | 0.99% |
Matarin Capital Management, LLC | 85,003 | $1,811,414,000 | 0.83% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 407,000 | $8,673,000 | 0.39% |
ICON ADVISERS INC/CO | 258,478 | $5,508,000 | 0.32% |
RMB Capital Management, LLC | 178,204 | $3,798,000 | 0.23% |
NEW AMSTERDAM PARTNERS LLC/NY | 159,470 | $3,398,000 | 0.23% |
GLOBEFLEX CAPITAL L P | 94,016 | $2,003,000 | 0.23% |
Convergence Investment Partners, LLC | 58,672 | $1,250,000 | 0.17% |